These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 6007876

  • 1. [Activator and inhibitor of fibrinolysis in the genital organs of the rat in the course of pregnancy].
    Januszko T, Buluk K.
    Acta Physiol Pol; 1966; 17(4):569-80. PubMed ID: 6007876
    [No Abstract] [Full Text] [Related]

  • 2. [On activators and inhibitors of fibrinolysis in the amniotic fluid and in extracts of the placenta, decidua and myometrium of interrupted and normally terminated pregnancies].
    Slunský R.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):236-43. PubMed ID: 4174664
    [No Abstract] [Full Text] [Related]

  • 3. [Activators and inhibitors of blood coagulation and fibrinolysis in the human placenta and myometrium].
    Uszyński M.
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1971; 16():159-90. PubMed ID: 5004447
    [No Abstract] [Full Text] [Related]

  • 4. [Thromboplastic and fibrinolytic activity of the tissues of pregnant uterus and the elements of fertilized ovum].
    Vdovina GF, Skipetrov VP, Azbukina LN.
    Vopr Okhr Materin Det; 1975 Jun; 20(6):75-9. PubMed ID: 1136329
    [No Abstract] [Full Text] [Related]

  • 5. [The clinical problems of fibrinolysis between the utero-placental and the feto-placental units in relation to the abortion].
    Oyanagi K.
    Zasshi Tokyo Ika Daigaku; 1970 Sep; 28(5):757-76. PubMed ID: 4259204
    [No Abstract] [Full Text] [Related]

  • 6. Plasminogen activator and urokinase inhibitor in myometrium, placenta, and amniotic fluid.
    Uszyński M, Uszyński-Folejewska R.
    Am J Obstet Gynecol; 1969 Dec 01; 105(7):1041-3. PubMed ID: 5352583
    [No Abstract] [Full Text] [Related]

  • 7. [Distribution of antibiotics in organs and tissues of pregnant guinea pigs under normal conditions and in Vibrio infection].
    Golikov AV.
    Antibiotiki; 1970 Feb 01; 15(2):171-3. PubMed ID: 5443097
    [No Abstract] [Full Text] [Related]

  • 8. Separation and characterization of two fibrinolytic inhibitors from human placenta.
    Uszynski M, Abildgaard U.
    Thromb Diath Haemorrh; 1971 Jun 30; 25(3):580-9. PubMed ID: 4998018
    [No Abstract] [Full Text] [Related]

  • 9. [Inhibitors of fibrinolysis in the human placenta. Histochemical study].
    Fornasari PM, Sora A, Bolis PF, Guaschino S.
    Ann Ostet Ginecol Med Perinat; 1977 Jun 30; 98(2):104-7. PubMed ID: 855972
    [No Abstract] [Full Text] [Related]

  • 10. Vitamin B6 supplementation during pregnancy and the vitamin-B6-status of the reproductive product.
    Reithmayer F, Roth-Maier DA, Kirchgessner M.
    Int J Vitam Nutr Res; 1984 Jun 30; 54(2-3):270-1. PubMed ID: 6500855
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of hexachlorcyclohexane gamma-isomer and sevin on sexual function].
    Trifonova TK, Gladenko IN, Shuliak VD.
    Veterinariia; 1970 Jun 30; 6():91-3. PubMed ID: 5529621
    [No Abstract] [Full Text] [Related]

  • 12. [Fibrinolytic homeostasis in pregnancy. I. Quantitative relations between pro- and anti-fibrinolytic factors. Clinical and experimental study].
    Giordano G.
    Minerva Ginecol; 1969 Jul 31; 21(14):888-92. PubMed ID: 4249426
    [No Abstract] [Full Text] [Related]

  • 13. Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
    Moniwa N.
    Pol J Pharmacol; 1996 Jul 31; 48(2):215-20. PubMed ID: 9112654
    [Abstract] [Full Text] [Related]

  • 14. Urokinase inhibitor in human placenta. A thromboelastographic evaluation.
    Uszyński M, Uszyńska-Folejewska R.
    Mater Med Pol; 1971 Jul 31; 3(4):15-9. PubMed ID: 5317354
    [No Abstract] [Full Text] [Related]

  • 15. [Plasminogen, antiplasmins and the rate of fibrinolysis in hypertension and atherosclerosis].
    Gritsiuk AI.
    Kardiologiia; 1968 May 31; 8(5):54-8. PubMed ID: 5671692
    [No Abstract] [Full Text] [Related]

  • 16. The role of placental urokinase inhibitor in toxemia of pregnancy.
    Terao T, Kobayashi T.
    Biol Res Pregnancy Perinatol; 1983 May 31; 4(4):145-51. PubMed ID: 6360225
    [Abstract] [Full Text] [Related]

  • 17. [Tryptazine penetration through the placental barrier].
    Boĭko SS, Smol'nikova NM.
    Farmakol Toksikol; 1975 May 31; 38(6):701-3. PubMed ID: 1227916
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of tissue activator by urokinase inhibitor.
    Kawano T, Uemura Y.
    Thromb Diath Haemorrh; 1971 May 31; 25(1):129-33. PubMed ID: 5577966
    [No Abstract] [Full Text] [Related]

  • 19. The significance of fibrinolysis in abortion.
    Soma H.
    Zasshi Tokyo Ika Daigaku; 1970 Mar 31; 28(2):343-50. PubMed ID: 4260254
    [No Abstract] [Full Text] [Related]

  • 20. Fibrinolytic activity of the pregnant uterus, decidua, and placenta in rat.
    Tympanidis K, Astrup T.
    Obstet Gynecol; 1968 Dec 31; 32(6):770-7. PubMed ID: 4193257
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.